June 16, 2023 /

Webinar: ENVISION Study Update with Sarepta Therapeutics

by: Parent Project Muscular Dystrophy

Sarepta’s Medical Director, Clinical Development discusses the company’s upcoming ENVISION study for SRP-9001.

Research & Clinical Trial Webinars, Webinars

Posted on June 16, 2023

You may also like

AGAMREE® Approval with Catalyst Pharmaceuticals, Inc.

AGAMREE® Approval with Catalyst Pharmaceuticals, Inc.

Posted on December 1, 2023

Care Webinars, Webinars

agamree, catalyst, vamorolone

Overview of Topline Results from Phase 3 EMBARK Study

Overview of Topline Results from Phase 3 EMBARK Study

Posted on November 13, 2023

Research & Clinical Trial Webinars, Webinars

AGAMREE Approval: What this means for you and your family

AGAMREE Approval: What this means for you and your family

Posted on November 6, 2023

Care Webinars, Webinars

Advocating for Access: Overview of Medicaid DUR and P&T Meetings

Advocating for Access: Overview of Medicaid DUR and P&T Meetings

Posted on October 31, 2023

Care Webinars, Webinars

feature, insurance, medicaid

Capricor Therapeutics: CAP-1002 HOPE-3 Program Update

Capricor Therapeutics: CAP-1002 HOPE-3 Program Update

Posted on October 30, 2023

Research & Clinical Trial Webinars, Webinars

Edgewise Therapeutics: A Novel Approach Designed to Protect Muscle in Becker Muscular Dystrophy

Edgewise Therapeutics: A Novel Approach Designed to Protect Muscle in Becker Muscular Dystrophy

Posted on October 24, 2023

Research & Clinical Trial Webinars, Webinars

edg-5506, edgewise

Supporting Families Through Decision Making

Supporting Families Through Decision Making

Posted on October 17, 2023

Care Webinars, Webinars

palliative care

Affinity Duchenne™ and Affinity Beyond™: Updates on Investigational RGX-202 from REGENXBIO

Affinity Duchenne™ and Affinity Beyond™: Updates on Investigational RGX-202 from REGENXBIO

Posted on October 13, 2023

Research & Clinical Trial Webinars, Webinars

12 3…23 »

Page 1 of 23

Join Our Mailing List